PKC412, inhibitor of the KIT tyrosine kinase, demonstrates efficacy in mast cell leukemia with the D816V KIT mutation. 45th Annual Meeting and Exhibition of the American-Society-of-Hematology Gotlib, J., Berube, C., Ruan, J., Growney, J., Dugan, K., Falkow, R., Rosamilia, M., Resta, D., Cohen, P., Fabbro, D., Heinrich, M., Gilliland, D. G., Coutre, S. AMER SOC HEMATOLOGY. 2003: 919A–919A

View details for Web of Science ID 000186536703420